Sirtris Major Buyout Premium From GlaxoSmithKline, Public Under a Year (SIRT, GSK)
GlaxoSmithKline (NYSE: GSK) has announced that it has entered into a definitive acquisition pact with Sirtris Pharmaceuticals Inc. (NASDAQ: SIRT). The drug giant will pay approximately $720 million via a cash tender…